Pokemon reduces Bcl-2 expression through NF- κ Bp65: a possible mechanism of hepatocellular carcinoma

被引:35
作者
Zhao, Xinkai [1 ,2 ]
Ning, Qiaoming [2 ]
Sun, Xiaoning [2 ]
Tian, De'an [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan 430030, Peoples R China
[2] Hainan Prov Peoples Hosp, Haikou 570311, Peoples R China
关键词
Pokemon; NF- kappa B p65; Bcl-2; Hepatocellular carcinoma; TRANSCRIPTION FACTOR POKEMON; CRYSTAL-STRUCTURE; BTB DOMAIN; INFLAMMATION; CANCER; COMPLEX;
D O I
10.1016/S1995-7645(11)60133-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
Objective: To investigate the relationship among Pokemon, NF- kappa B p65 and Bcl-2 in hepatoma cells. Methods: HCC cell HepG2, SMMC7721 and human fetal liver cell line LO2 cells were used, and expression of Pokemon, NF- kappa B p65 and Bcl-2 in three cells were detected by real-time PCR and western blot. Then siRNA of Pokemon was applied to inhibit the expression of Pokemon and NF- kappa B p65 and apoptotic rate was determined by flow cytometric analysis. Results: Expressions of Pokemon, NF- kappa B p65 and Bcl-2 in human hepatoma cell HepG2, SMMC7721 expression were significantly higher than those in human embryonic stem cells LO2. siRNA of Pokemon inhibited the expression of Pokemon, NF- kappa B p65 and Bcl-2 in liver cancer cells, and significantly increased apoptosis of liver cells. While siRNA of NF- K B p65 inhibited the expression of NF- kappa B p65 and Bcl-2, but Pokemon expression in hepatoma cells had no significant change. Conclusions: The proto-oncogene Pokemon can inhibit P14ARF by specific transcription regulation of cell cycle and can induce tumors. In addition, Pokemon can regulate NF- kappa B p65 through the expression of apoptosis repressor, and promote the development of liver cancer. It suggests signal network in the liver include the regulation of new non-classical NF- kappa B regulatory pathway.
引用
收藏
页码:492 / 497
页数:6
相关论文
共 27 条
[1]
Miz1 is required for early embryonic development during gastrulation [J].
Adhikary, S ;
Peukert, K ;
Karsunky, H ;
Beuger, V ;
Lutz, W ;
Elsässer, HP ;
Möröy, T ;
Eilers, M .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (21) :7648-7657
[2]
Regulation of the p14ARF-Mdm2-p53 pathway: An overview in breast cancer [J].
Agrawal, Anshu ;
Yang, Jianhui ;
Murphy, Richard F. ;
Agrawal, Devendra K. .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2006, 81 (02) :115-122
[3]
Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer [J].
Apostolopoulou, K. ;
Pateras, I. S. ;
Evangelou, K. ;
Tsantoulis, P. K. ;
Liontos, M. ;
Kittas, C. ;
Tiniakos, D. G. ;
Kotsinas, A. ;
Cordon-Cardo, C. ;
Gorgoulis, V. G. .
JOURNAL OF PATHOLOGY, 2007, 213 (03) :294-302
[4]
Nuclear factor-κB and liver carcinogenesis [J].
Arsura, M ;
Cavin, LG .
CANCER LETTERS, 2005, 229 (02) :157-169
[5]
Downregulation of proapoptotic proteins Bax and Bcl-Xs in p53 overexpressing hepatocellular carcinomas [J].
Beerheide, W ;
Tan, YJ ;
Teng, E ;
Ting, AE ;
Jedpiyawongse, A ;
Srivatanakul, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (01) :54-61
[6]
Evaluation of nuclear factor-κB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma [J].
Chan, CF ;
Yau, TO ;
Jin, DY ;
Wong, CM ;
Fan, ST ;
Ng, IOL .
CLINICAL CANCER RESEARCH, 2004, 10 (12) :4140-4149
[7]
Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors [J].
Chen, WY ;
Zeng, XB ;
Carter, MG ;
Morrell, CN ;
Yen, RWC ;
Esteller, M ;
Watkins, DN ;
Herman, JG ;
Mankowski, JL ;
Baylin, SB .
NATURE GENETICS, 2003, 33 (02) :197-202
[8]
Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene [J].
Davies, JM ;
Hawe, N ;
Kabarowski, J ;
Huang, QH ;
Zhu, J ;
Brand, NJ ;
Leprince, D ;
Dhordain, P ;
Cook, M ;
Morriss-Kay, G ;
Zelent, A .
ONCOGENE, 1999, 18 (02) :365-375
[9]
NF-κB activation represses tumor necrosis factor-α-induced autophagy [J].
Djavaheri-Mergny, Mojgan ;
Amelotti, Manuela ;
Mathieu, Julie ;
Besancon, Francoise ;
Bauvy, Chantal ;
Souquere, Sylvie ;
Pierron, Gerard ;
Codogno, Patrice .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (41) :30373-30382
[10]
Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis [J].
Elsharkawy, Ahmed M. ;
Mann, Derek A. .
HEPATOLOGY, 2007, 46 (02) :590-597